Scott, You raise some good points, but since th

Scott,

You raise some good points, but since there are probably only a small number of actual shareholders, and many of us on this board are already heavily loaded with NNLX stock, all it takes is a few sellers to lower the price.

There is simply no large volume going on here and very few know about the company. So, here we sit with the fastest test in the world for various indications and yet at the moment no investors seem willing to step forth to fund a plant expansion or the development of the N-Assay TB Test for the Africa project.

Why is that? I really don't know but would think that the risk/reward ratio for investors would be very attractive, especially since, as you pointed out in an earlier post, if we just captured 15% of the $600 million dollar GBS market that would be $90 million in sales just for the GBS indicator alone, and then throw in e-coli, TB, etc..

I can understand Brett's frustration, but he's also a large shareholder and has a real strong personal incentive to succeed here.